Related Experiment Video
Updated: Aug 9, 2026

Semi-Quantitative Analysis of Peptidoglycan by Liquid Chromatography Mass Spectrometry and Bioinformatics
Published on: October 13, 2020
Peptidoglycan hydrolase fusions maintain their parental specificities
David M Donovan1, Shengli Dong, Wes Garrett
1Biotechnology and Germplasm Lab, ANRI, ARS, US Department of Agriculture, Bldg. 230, Room 104, BARC-East, 10300 Baltimore Ave., Beltsville, MD 20705-2350, USA. ddonovan@anri.barc.usda.gov
Novel antimicrobial proteins targeting specific bacteria were developed to combat antibiotic resistance. These fusion proteins show promise for creating mastitis-resistant cattle and as selective agents against human pathogens.
Area of Science:
- Microbiology
- Biotechnology
- Veterinary Science
Background:
- Rising antibiotic resistance necessitates new antimicrobial strategies.
- Peptidoglycan hydrolases (endolysins) offer targeted bacterial lysis, potentially reducing resistance.
- Mastitis in dairy cattle is a significant economic and animal welfare concern.
Purpose of the Study:
- To develop novel antimicrobial fusion proteins for combating bacterial pathogens.
- To assess the efficacy of these proteins in a milk-like environment for potential use in transgenic cattle.
- To evaluate the potential of these antimicrobials against human pathogens and their suitability for reducing broad-spectrum antibiotic use.
Main Methods:
- Fusion of S. agalactiae bacteriophage B30 endolysins (full-length and truncated) with Staphylococcus simulans lysostaphin.
- Testing lytic activity against target pathogens (S. aureus, S. agalactiae) and lactic acid bacteria.
- Assessing activity in a milk-like environment and stability after pasteurization.
- Evaluating expression and cellular effects in cultured mammalian cells.
Main Results:
- Both full-length and truncated endolysin-lysostaphin fusions exhibited lytic activity against streptococcal pathogens and S. aureus.
- The C-terminal SH3b domain of the B30 endolysin was found to be dispensable for lytic activity.
- Fusion proteins were active in a milk-like environment and against some lactic acid bacteria, but inactivated by pasteurization.
- Expression in mammalian cells showed no obvious deleterious effects.
Conclusions:
- Novel endolysin-lysostaphin fusion proteins are effective against key mastitis pathogens and S. aureus.
- These fusion proteins are candidates for developing mastitis-resistant transgenic cattle.
- The antimicrobials show potential for selective targeting of multiple human pathogens, possibly reducing reliance on broad-spectrum antibiotics.
Related Concept Videos
Peptidoglycan Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis
Proteoglycans
Tagging and Fusion Proteins
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
